• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 91 of 100
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health
Valeant beat expectations in 3Q thanks to U.S. skin business
By Reuters and Fortune EditorsOctober 19, 2015
Hillary Clinton in the first Democratic presidential debate in Las Vegas on Oct. 13
Commentary
Clinton’s big pharma takedown plan has some serious issues
By Chris Ford and Bethany CiancioloOctober 16, 2015
Democratic Candidates Attend New Hampshire Democratic Party Convention
Leadership
Bernie Sanders rejects drug price-raising CEO’s donation: ‘We don’t want his stinkin’ money’
By Michal AddadyOctober 16, 2015
CNBC NEWS-- Pictured: Jeb Bush, former Governor of Florida and 2016 presidential election candidate, in an interview at the Parlor City Pub and Eatery in Cedar Rapids, Iowa on September 22, 2015 -- (Photo by: Mary Stevens/CNBC/NBCU Photo Bank)
Health
Jeb Bush’s health care plan would dismantle Obamacare
By Laura LorenzettiOctober 15, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health
Valeant under federal investigation for how it prices drugs
By Laura LorenzettiOctober 15, 2015
Johnson & Johnson Products Ahead Of Earnings
Health
Johnson & Johnson struggles to boost drug sales even as profits gain
By Laura LorenzettiOctober 13, 2015
Eli Lilly & Co's Zyprexa schizophrenia drug is pictured in a
Finance
Eli Lilly adds one more to roster of failed heart drugs, and it won’t be the last
By Laura LorenzettiOctober 12, 2015
General Views of Eli Lilly & Co.
Health
Why drug maker Eli Lilly’s stock price is down big today
By John KellOctober 12, 2015
Hedge fund manager Bill Ackman
Finance
The strange thing about Bill Ackman’s defense of Valeant’s drug prices
By Stephen GandelOctober 7, 2015
AmerisourceBergen pays $2.58 billion to buy PharMEDium
Health
AmerisourceBergen pays $2.58 billion to buy PharMEDium
By Laura LorenzettiOctober 6, 2015
Symbolic - biotechnology - genetic engineering
Health
TPP trade deal: Even more bad news for biotech industry
By Laura LorenzettiOctober 5, 2015
Japan Scenics
Health
This Japanese pufferfish could be the ultimate painkiller
By Laura LorenzettiSeptember 30, 2015
Why drug price controversy is great news for this hedge fund manager
Finance
Why drug price controversy is great news for this hedge fund manager
By Jen WiecznerSeptember 30, 2015
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
Health
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
By Laura LorenzettiSeptember 29, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health
Biotech stocks dive as lawmakers take aim at Valeant for drug price hikes
By Laura LorenzettiSeptember 28, 2015
1...
  • 89
  • 90
  • 91
  • 92
  • 93
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.